Explainable Cross-Disease Reasoning for Cardiovascular Risk Assessment from Low-Dose Computed Tomography

Researchers have developed an explainable AI framework that jointly assesses lung and cardiovascular health from low-dose chest CT scans by modeling cross-disease physiological interactions. The system achieves 91.9% AUC for cardiovascular disease screening and outperforms cardiac-specific baselines by explicitly reasoning through pulmonary findings to inform heart risk predictions.

This research represents a meaningful advance in medical AI by addressing a fundamental limitation in current diagnostic approaches: the treatment of disease domains as isolated silos despite their physiological interdependence. The framework demonstrates that pulmonary findings can meaningfully inform cardiovascular risk assessment when properly integrated through mechanistic reasoning rather than simple feature concatenation.

The technical architecture—combining frozen lung-risk priors with agentic reasoning modules and cardiac feature extraction—reflects a shift toward interpretable AI systems in clinical settings. By producing natural-language rationales alongside predictions, the framework addresses a critical barrier to AI adoption in healthcare: the need for clinician transparency and audit trails. This contrasts with black-box deep learning approaches that dominate contemporary medical imaging.

The validation on the National Lung Screening Trial cohort, a real-world longitudinal dataset, strengthens the findings beyond controlled benchmarks. The reported AUC of 0.919 for screening and 0.838 for mortality prediction suggests practical clinical utility, though the gap between screening and mortality prediction accuracy warrants investigation. The controlled experiments systematically ruling out explanations (additional visual features, fixed rules, single reasoning backends) demonstrate methodological rigor.

For the broader healthcare AI ecosystem, this work signals market demand for interpretable cross-domain reasoning systems. Medical imaging AI vendors and healthcare IT companies increasingly recognize that regulatory approval and clinical adoption require explainability. The framework's approach of grounding predictions in medical knowledge graphs rather than pure data-driven learning may become a competitive differentiator as healthcare systems prioritize trustworthy AI implementations.

• →Cross-disease reasoning framework achieves 0.919 AUC for cardiovascular disease screening by integrating pulmonary findings with cardiac analysis
• →Natural-language explanations and mechanistic reasoning pathways increase clinical auditability and trustworthiness compared to black-box models
• →Validation confirms performance gains stem from explainable cross-organ reasoning rather than additional imaging features alone
• →Framework demonstrates practical advantage of knowledge-grounded AI architectures over foundation models for specialized medical imaging tasks
• →Results suggest market opportunity for interpretable multi-domain diagnostic systems in clinical settings